Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Tod

Showing results (11-20 of 126) with videos related to

Pageof 13
Sort By:
Therapie|January 1, 1993
[Value of the theory of the optimal sampling scheme for bioequivalence studies]M Tod, O Petitjean, P Nicolas
Annales Francaises D'Anesthesie Et De Reanimation|October 27, 2004
[Clinical applications of intravenous anaesthetics pharmacology: the example of hypnotics and opioids]F Lagneau, M Tod, J Marty
Antimicrobial Agents and Chemotherapy|April 1, 1996
Pharmacokinetic interaction between cefdinir and two angiotensin-converting enzyme inhibitors in ratsA Jacolot, M Tod, O Petitjean
Journal of Pharmaceutical and Biomedical Analysis|June 1, 1995
Influence of methodological aspects on tissue drug concentration estimationO Petitjean, M Tod, K Louchahi
The International Journal on Drug Policy|December 13, 2016
Reasons for missed appointments with a hepatitis C outreach clinic: A qualitative studyRay Poll, Peter Allmark, Angela M Tod
Journal of Advanced Nursing|November 8, 2002
Ethical review of health service research in the UK: implications for nursingA M Tod, P Nicolson, P Allmark
European Journal of Cancer Care|October 17, 2009
Living with mesothelioma. A literature reviewS Moore, L Darlison, A M Tod
Clinical Pharmacokinetics|December 12, 2001
Individualising aminoglycoside dosage regimens after therapeutic drug monitoring: simple or complex pharmacokinetic methods?M M Tod, C Padoin, O Petitjean
Clinical Pharmacology and Therapeutics|August 26, 2011
Genotype-based quantitative prediction of drug exposure for drugs metabolized by CYP2D6M Tod, S Goutelle, M C Gagnieu, et al.
Journal of Advanced Nursing|January 17, 2008
Diagnostic delay in lung cancer: a qualitative studyAngela M Tod, Jacqueline Craven, Peter Allmark
Pageof 13

Showing results (11-20 of 126) with videos related to

Sort By:
Pageof 13
Therapie|January 1, 1993
[Value of the theory of the optimal sampling scheme for bioequivalence studies]M Tod, O Petitjean, P Nicolas
Annales Francaises D'Anesthesie Et De Reanimation|October 27, 2004
[Clinical applications of intravenous anaesthetics pharmacology: the example of hypnotics and opioids]F Lagneau, M Tod, J Marty
Antimicrobial Agents and Chemotherapy|April 1, 1996
Pharmacokinetic interaction between cefdinir and two angiotensin-converting enzyme inhibitors in ratsA Jacolot, M Tod, O Petitjean
Journal of Pharmaceutical and Biomedical Analysis|June 1, 1995
Influence of methodological aspects on tissue drug concentration estimationO Petitjean, M Tod, K Louchahi
The International Journal on Drug Policy|December 13, 2016
Reasons for missed appointments with a hepatitis C outreach clinic: A qualitative studyRay Poll, Peter Allmark, Angela M Tod
Journal of Advanced Nursing|November 8, 2002
Ethical review of health service research in the UK: implications for nursingA M Tod, P Nicolson, P Allmark
European Journal of Cancer Care|October 17, 2009
Living with mesothelioma. A literature reviewS Moore, L Darlison, A M Tod
Clinical Pharmacokinetics|December 12, 2001
Individualising aminoglycoside dosage regimens after therapeutic drug monitoring: simple or complex pharmacokinetic methods?M M Tod, C Padoin, O Petitjean
Clinical Pharmacology and Therapeutics|August 26, 2011
Genotype-based quantitative prediction of drug exposure for drugs metabolized by CYP2D6M Tod, S Goutelle, M C Gagnieu, et al.
Journal of Advanced Nursing|January 17, 2008
Diagnostic delay in lung cancer: a qualitative studyAngela M Tod, Jacqueline Craven, Peter Allmark
Pageof 13